Winfried Häuser

Learn More
OBJECTIVE To develop a fibromyalgia (FM) survey questionnaire for epidemiologic and clinical studies using a modification of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia (ACR 2010). We also created a new FM symptom scale to further characterize FM severity. METHODS The ACR 2010 consists of 2 scales, the(More)
OBJECTIVE To evaluate fibromyalgia in the general population with emphasis on prevalence, dimensionality, and somatic symptom severity. METHODS We studied 2,445 subjects randomly selected from the German general population in 2012 using the American College of Rheumatology 2010 preliminary diagnostic criteria for fibromyalgia, as modified for survey(More)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations Gert Van Assche⁎, Axel Dignass⁎⁎, Bernd Bokemeyer, Silvio Danese, Paolo Gionchetti, Gabriele Moser, Laurent Beaugerie, Fernando Gomollón, Winfried Häuser, Klaus Herrlinger, Bas Oldenburg, Julian Panes, Francisco Portela, Gerhard Rogler,(More)
OBJECTIVES To synthesise the available evidence on pharmacological and non-pharmacological interventions recommended for fibromyalgia syndrome (FMS). METHODS Electronic databases including MEDLINE, PsycINFO, Scopus, the Cochrane Controlled Trials Registry and the Cochrane Library were searched for randomised controlled trials comparing any therapeutic(More)
BACKGROUND The role of antidepressants in the management of fibromyalgia syndrome (FMS) still needs to be determined. OBJECTIVE The objective of this study was to provide a quantitative analysis (meta-analysis) of the efficacy and harms of antidepressants in the management of adult FMS patients. DATA SOURCES The data sources used were the databases(More)
BACKGROUND Nocebo phenomena are common in clinical practice and have recently become a popular topic of research and discussion among basic scientists, clinicians, and ethicists. METHODS We selectively searched the PubMed database for articles published up to December 2011 that contained the key words "nocebo" or "nocebo effect." RESULTS By definition,(More)
OBJECTIVE To systematically review the efficacy of multicomponent treatment of fibromyalgia syndrome (FMS). METHODS We screened Medline, PsychINFO, Scopus, and the Cochrane Library (through December 2007), as well as reference sections of original studies, reviews, and evidence-based guidelines. Randomized controlled trials (RCTs) on the multicomponent(More)
BACKGROUND There are no up-to-date, representative studies on the frequency of maltreatment (abuse or neglect) among children and adolescents in Germany. METHODS In a cross-sectional study, standardized questionnaires were administered to persons aged 14 and older in a representative sample of the German population. Statistics on maltreatment in childhood(More)
UNLABELLED Duloxetine (DLX), milnacipran (MLN), and pregabalin (PGB) are the only drugs licensed by the US Food and Drug Administration (FDA) for fibromyalgia syndrome (FMS). Evidence on the comparative benefits and harms is still accruing. The authors searched MEDLINE, SCOPUS, Cochrane Central Register of Controlled Trials, and sought unpublished data from(More)